Delivery Order SPE2DB22D3016-SPE2DB25FAYB6
- Not listed
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,047.43 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,059.20 on August 29, 2025, for supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency Medical Supply Chain, a defense agency component, with an ultimate completion date of September 2, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,107.40 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for MENVEO A-C-Y-W vaccine kits, valued at $2,014.32 with a firm fixed price structure. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a competitive, non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.80 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract, executed on November 19, 2024, with an ultimate completion date of November 20, 2024, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,090.46 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kit (2 vials). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAYB6Delivery Order
The Defense Logistics Agency awarded a competitive delivery order valued at $8,656.86 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The order, issued on June 2, 2025 with an ultimate completion date of June 3, 2025, utilizes firm fixed pricing and carries no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child delivery order drawn from AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates competitive capability across diverse pharmaceutical and medical supply categories, ranging from specialty medications and vaccines to medical devices and diagnostics. As a prime contractor under the DLA's Pharmaceutical Prime Vendor program, AmerisourceBergen maintains flexibility to fulfill ongoing federal healthcare requirements across multiple therapeutic domains in support of military personnel and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 6/2/25 |